𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mycophenolate mofetil reduces calcineurin inhibitor–induced side effects after liver transplantation

✍ Scribed by R Pfitzmann; J Klupp; J.M Langrehr; R Neuhaus; G Junge; U Settmacher; T Steinmüller; P Neuhaus

Book ID
117232686
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
51 KB
Volume
34
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term effects of calcineurin inhibit
Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation
✍ Caroline Créput; Frederique Blandin; Benjamin Deroure; Bruno Roche; Faouzi Salib 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

Calcineurin inhibitors (CNIs) are the cornerstone of immunosuppression after liver transplantation. However, CNI treatment is frequently associated with chronic renal failure (CRF). The reduction or interruption of CNI may reduce renal failure. We prospectively studied 49 liver recipients treated wi

Mycophenolate mofetil in combination wit
Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation
✍ Georges-Philippe Pageaux; Lionel Rostaing; Yvon Calmus; Christophe Duvoux; Clair 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

The purpose of the study was to introduce mycophenolate mofetil (MMF) in liver transplant recipients with renal dysfunction to decrease calcineurin inhibitor (CNI) dosages without increasing rejection risk. In this prospective, multicenter, randomized study, chronic CNI-related renal dysfunction was